Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action Convening, a national gathering committed to strengthening prostate cancer care, support, and outcomes for veterans. Taking place ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling advanced prostate cancer. Experts at The Institute of Cancer Research, London, ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before the cancer comes back. Researchers at UCLA have found that a blend of a ...

Charities fought for more than three years to end a postcode lottery in access to the drug.

Prostate Cancer Progress: Novel Immunotherapy Agent Enoblituzumab Shows Potential in Clinical Trials for High-Risk Patients NEW YORK, NY, USA, June 22, 2023 ...

PROSTATE cancer has become the most common form of the disease in Britain for the first time. Analysis of NHS figures by ...